Pacific Biosciences Of California (PACB) Other Operating Expenses (2015 - 2026)

Pacific Biosciences Of California's Other Operating Expenses history runs 8 years deep, the most recent figure standing at $45.8 million for Q1 2026.

• On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $45.8 million in Q1 2026; TTM through Mar 2026 was $48.3 million, a 75.39% decrease from a year earlier, with the FY2025 full-year figure at $360.8 million, up 78.94% from the prior year.
• Other Operating Expenses rose to $45.8 million in Q1 2026 per PACB's latest filing, from $833000.0 in the prior quarter.
• Across five years, Other Operating Expenses topped out at $97.4 million in Q2 2024 and bottomed at -$5.4 million in Q2 2022.
• The 5-year median for Other Operating Expenses is $4.4 million (2022), against an average of $17.1 million.
• Across the five-year window, Other Operating Expenses soared 4832.76% in 2024 and slumped 99.14% in 2025, its largest moves.
• Year by year, Other Operating Expenses stood at $4.6 million in 2022, then jumped by 41.71% to $6.5 million in 2023, then surged by 1342.28% to $94.0 million in 2024, then sank by 99.11% to $833000.0 in 2025, then surged by 5397.72% to $45.8 million in 2026.
• Per Business Quant, the three latest PACB Other Operating Expenses figures stand at $45.8 million (Q1 2026), $833000.0 (Q4 2025), and $833000.0 (Q3 2025).